India Neurology Devices Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report 2026-2030

India's neurology devices market represents one of the fastest-growing segments within the country's broader medical technology sector. The market covers a wide range of products including neurovascular implants, neuromodulation systems, interventional neuroradiology equipment, and neurosurgical instruments. Domestic production is gradually increasing, though the market remains significantly reliant on imported devices from international manufacturers.

• •The market spans neurovascular, neuromodulation, interventional neuroradiology, and neurosurgery device categories
• •Imported devices currently dominate market share, though local manufacturing is expanding under government initiatives
• •Urban hospitals and specialty neurology centers represent the primary demand centers

Rising prevalence of neurological disorders is a primary catalyst, with stroke, epilepsy, and neurodegenerative conditions becoming increasingly common across India's aging population. Enhanced healthcare accessibility through government insurance schemes and expanded hospital infrastructure in tier-2 and tier-3 cities is accelerating adoption. Medical tourism and growing patient awareness about advanced treatment options further contribute to market expansion.

• •Increasing incidence of stroke and neurodegenerative diseases linked to lifestyle changes and demographic shifts
• •Government healthcare initiatives improving insurance coverage and hospital access in underserved regions
• •Rising medical tourism and growing acceptance of minimally invasive neuro-interventional procedures

Neurovascular devices including coils, stents, and embolization systems constitute a significant portion of the market, alongside neuromodulation devices such as deep brain stimulators and spinal cord stimulators. Interventional neuroradiology equipment and hydrocephalus shunts represent additional key product segments. Demand is concentrated in major metropolitan areas including Mumbai, Delhi, Bangalore, and Chennai, though tier-2 cities are witnessing growing adoption as healthcare networks expand.

• •Neurovascular and neuromodulation devices are the largest product segments by revenue
• •Tertiary care hospitals and specialty neurology clinics are the primary end users
• •Western and southern regions lead in adoption, with northern and eastern markets showing emerging potential

What are the recent trends and outlook?

The market is expected to sustain steady growth through the coming decade, supported by continued healthcare infrastructure development and rising disease burden. Technological advancements in minimally invasive procedures, robotics-assisted surgery, and digital health integration are shaping future demand patterns. Domestic manufacturing incentives and price regulation mechanisms will likely influence competitive dynamics and affordability outcomes over the forecast horizon.

• •Growing adoption of flow diverters, bioresorbable stents, and next-generation neuromodulation platforms
• •Increasing hospital investment in hybrid operating rooms and advanced neuro-imaging systems
• •Potential for expanded domestic production to reduce import dependency and device costs